Cite
HARVARD Citation
Colman, R. et al. (2023). Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Alimentary pharmacology & therapeutics. 57 (5), pp. 524-539. [Online].